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Background: Intakes of omega-3 (n-3) fatty acids (FA) are associated with several health benefits. The aim of this
study was to verify whether intakes of n-3 FA estimated from a food frequency questionnaire (FFQ) correlate with
n-3 FA levels measured in plasma phospholipids (PL).
Methods: The study sample consisted of 200 French-Canadians men and women aged between 18 to 55 years.
Dietary data were collected using a validated FFQ. Fasting blood samples were collected and the plasma PL FA
profile was measured by gas chromatography.
Results: Low intakes of n-3 long-chain FA together with low percentages of n-3 long-chain FA in plasma PL were
found in French-Canadian population. Daily intakes of eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA)
and docosahexaenoic acid (DHA) were similar between men and women. Yet, alpha-linolenic acid (ALA) and total
n-3 FA intakes were significantly higher in men compared to women (ALA: 2.28 g and 1.69 g, p< 0.0001, total n-3
FA: 2.57 g and 1.99 g, p< 0.0001; respectively). In plasma PL, DPA and DHA percentages were significantly different
between men and women (DPA: 1.03% and 0.88%, p< 0.0001, DHA: 3.00% and 3.43%, p = 0.0005; respectively).
Moreover, DHA (men: r = 0.52, p< 0.0001; women: r = 0.57, p< 0.0001) and total n-3 FA (men: r = 0.47, p< 0.0001;
women: r = 0.52, p< 0.0001) intakes were positively correlated to their respective plasma PL FA levels. In women,
EPA (r = 0.44, p< 0.0001) and DPA (r = 0.23, p = 0.02) intakes were also correlated respectively with EPA and DPA
plasma PL FA percentages.
Conclusion: Estimated n-3 long-chain FA intake among this young and well-educated French-Canadian population
is lower than the recommendations. Further, FFQ data is comparable to plasma PL results to estimate DHA and
total n-3 FA status in healthy individuals as well as to evaluate the EPA and DPA status in women. Overall, this FFQ
could be used as a simple, low-cost tool in future studies to rank n-3 FA status of individuals.
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Intakes of omega-3 (n-3) fatty acids (FA) are associated
with numerous health benefits [1]. Particularly, n-3 poly-
unsaturated fatty acids (PUFA) help to modulate factors
contributing to the metabolic syndrome characterised by
abdominal obesity, insulin resistance, dyslipidemia and
hypertension [2-4]. n-3 PUFA are also known to have
beneficial effects on cardiovascular disease risk [5-8] and
favourable effects on symptoms of depression [9], weight
status [10], postprandial satiety [11], insulin resistance
[12] and inflammatory diseases [13]. Thus, there is a
need to have an accurate and non-invasive tool to esti-
mate n-3 PUFA intakes and enable analyses on health in
large epidemiological studies.
Numerous food frequency questionnaires (FFQ) have
previously been developed to estimate specifically FA in-
take. In the literature, validation studies for n-3 FA spe-
cific FFQ were conducted against other reported dietary
questionnaires, biomarkers or other methods [14,15].
The current FFQ was previously validated with a three-
day food record that demonstrated significant correl-
ation coefficients for eicosapentaenoic acid (20:5; EPA)
(r = 0.33, p ≤ 0.01) and docosahexaenoic acid (22:6;
DHA) (r = 0.30, p≤ 0.01) in French-Canadian women
[16]. Correlations between the FFQ and the three-day
food record have not been examined for other FA, such
as alpha-linolenic acid (18:3; ALA) and docosapentae-
noic acid (22:5; DPA).
Plasma n-3 FA are considered good biomarkers to
evaluate the validity of dietary recall methods of n-3 FA
intake since they are largely derived from exogenous
sources [17]. However, tissue n-3 FA levels are subjected
to individual variations due to digestion, absorption, me-
tabolism, use of the FA as energy, genetic factors, sex
hormones, etc. [14,18-20]. In the same manner, dietary
recall methods may inherit inaccuracies due to underre-
porting of dietary fat intake or errors associated with
databases [17,19,21]. Thus, the use of biomarkers may
be a good method to validate an FFQ. Overall, the ob-
jective of this study was to verify whether n-3 dietary
intakes estimated by a validated FFQ correlate with n-3




200 subjects, including 100 men and 100 women, aged be-
tween 18 and 55 years were randomly selected from a pre-
vious study conducted in two phases from May 2004 to
December 2004 and from March 2006 to April 2007 in
the Quebec City metropolitan area [22]. Briefly, advertise-
ments in local newspapers and radio stations, in addition
to electronic group messages sent to university and hos-
pital employees, were used to recruit participants. Thefollowing data was collected from each of the study parti-
cipants during the visit: lifestyle habits and socio-
demographic questionnaires, anthropometric measures,
fasting blood samples, and the FFQ. All participants
signed an informed consent form to participate to this
study, which has been approved by the Ethics Committee
of Laval University.
Dietary intake
A FFQ was used to assess dietary intakes of Quebecers.
This FFQ has previously been validated and evaluated
for reproducibility in the French-Canadian population
[16,23]. The FFQ had 91 items. The nutrient content of
each item on the FFQ was selected from the Nutrition
Data System (NDS) for Research (Nutrition Coordin-
ation Center, University of Minnesota, Minneapolis,
MN) in 2001. Specifically, the nutrients values of the
food items from NDS were chosen based on the nutrient
values which represent foods available in the Quebec
market. In addition, these nutrient values were com-
pared to the Canadian databases for accuracy. Frequency
of food consumed was determined by asking how often
a participant consumed each item per day, week, month
or none at all during the previous month. To obtain a
better estimation of the portion consumed by the par-
ticipant, examples of portion size were provided. Infor-
mation on n-3 supplement intake was also collected and
included in total n-3 intake estimates.
Fatty acid composition of plasma phospholipids
Fasting blood samples were collected into vacutainer tubes
containing EDTA. After centrifugation, plasma was ali-
quoted and stored. Samples were stored at −80 °C for 2 to
5 years. Erythrocytes are considered the gold standard to
measure the long-term n-3 status. Yet, numerous studies
have reported strong correlations between FA content of
erythrocytes and plasma PL; therefore, plasma PL may be
considered as a valid biomarker to reflect n-3 status over
the last month [21,24]. Extraction of plasma lipids was
made using a chloroform-methanol mixture (2:1, vol/vol).
Total PL were separated by thin layer chromatography
using a combination of isopropyl ether and acetic acid and
fatty acids of isolated PL were then methylated. Capillary
gas chromatography was then used to obtain FA profiles.
The technique used for plasma analyses has been previ-
ously validated [25]. Values of FA levels are expressed as
percent of total FA in plasma PL.
Statistical analysis
Means (±SDs) were calculated by sex for dietary intakes,
plasma PL n-3 FA percentages and other subjects’ charac-
teristics. Relationships between n-3 PUFA dietary intakes
and plasma PL n-3 FA levels were assessed by Spearman’s
correlation coefficients. Correlations were computed for
Table 2 Daily dietary intakes
Men (n = 100) Women (n= 100)
Mean SD Mean SD p
Energy, kcal 2810 854 2140 533 <0.0001
Carbohydrates, % of energy 47.3 6.2 49.8 6.5 0.005
Proteins, % of energy 17.0 2.5 16.7 2.2 0.34
Fat, % of energy 34.3 5.1 32.8 5.5 0.05
Saturated fat, % of energy 11.9 2.6 11.3 2.6 0.15
MUFA, % of energy 14.1 2.5 13.4 2.7 0.06
PUFA, % of energy 5.6 1.3 5.5 1.4 0.51
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ergy intake. With a sample size of 100 individuals in each
group calculated with 80% power and P≤ 0.05 (two-sided),
we can expect to find a correlation coefficient of 0.26 or
stronger [26]. In addition, participants were classified into
quartiles according to FFQ- dietary intakes and plasma
PL n-3 FA levels. The accuracy of the FFQ to classifying
individuals by gender into same or adjacent plasma-
determined quartiles was determined. All analyses were
performed with SAS, version 9.1 (SAS Institute Inc.,
Cary, North Carolina). P-values ≤0.05 were considered
statistically significant.ALA, g 2.28 1.13 1.69 0.76 <0.0001
EPA, g 0.08 0.08 0.09 0.09 0.28
DPA, g 0.04 0.02 0.03 0.02 0.29
DHA, g 0.17 0.14 0.18 0.15 0.70
total n-3, g 2.57 1.14 1.99 0.85 <0.0001
total n-3 : ALA + EPA +DPA+DHA.Results
Analyses were performed on 200 participants (100 men
and 100 women). Subjects’ characteristics are presented
in Table 1. The sample consisted of a young adult popu-
lation with a high percentage of study participants hav-
ing a college or university degree. Further, there was no
significant difference between men and women for these
presented subjects’ characteristics. A personal income
over 50,000$ (CDN)/year was more common in men
than in women. Ten percent of participants were consid-
ered as current smokers.
Men had a significantly greater energy intake than
women and a higher proportion of energy intake coming
from fat. Women, on the other hand, had a higher pro-
portion of energy intake derived from carbohydrates. As
presented in Table 2, EPA, DPA and DHA daily intakes
were comparable for men and women. However, ALA
and total n-3 FA intakes were significantly higher in
men than in women. From the FFQ data, ALA sources
were mainly from higher-fat processed foods and canola
oil. The main sources of DPA included meat and fishTable 1 Subject’s characteristics (n = 200)
Women, % 50
Age (years) 34.3 10.2
BMI (Kg/m²) 29.1 6.2
Education
high school, % 9.5
college degree, % 32.5
university degree, % 58.0
Personal income, $ *
< 12,000, % 27.6
12,000 – 29,999, % 25.6
30,000 – 49,999, % 26.8
≥ 50,000, % 20.0
Current smokers, % * 9.6
Mean± SD.
: missing values for 2 women.products. The main contributors of EPA and DHA were
the fried fish and seafood as well as fish, molluscs and
crustaceans. Further, approximately 12.1% of subjects
reported taking n-3 capsules as a dietary supplement.
Mean plasma PL FA are shown in Table 3. Significant
sex differences were observed for plasma PL DPA and
DHA. Women presented the highest percentage of
plasma PL DHA and men had greater plasma PL DPA
percentage. In men and women, plasma PL DHA per-
centage was the FA found in the greatest percentage
whereas ALA was found in the lowest percentage. In
addition, women tended to have a higher percentage of
total n-3 FA in plasma PL than men.
Correlations between dietary intakes of n-3 FA and the
levels of the same FA in plasma are presented in Table 4.
Adjustment for n-3 supplementation did not alter the
correlation coefficients (data not shown). In general, sig-
nificant and positive relationships were observed for
DHA and total n-3 FA in both genders. In women, sig-
nificant and positive relationships were also observed for
EPA and for DPA. On the other hand, no relationships
were found for ALA in either gender.
Further, the accuracy of the FFQ to rank individuals
into the same or adjacent plasma quartiles was 79% andTable 3 Participants plasma PL FA concentrations
Men (n = 100) Women (n= 98)
Mean SD Mean SD p
ALA, % 0.15 0.14 0.19 0.14 0.06
EPA, % * 1.09 0.56 1.08 0.61 0.82
DPA, % 1.03 0.16 0.88 0.24 <0.0001
DHA, % 3.00 0.80 3.43 0.92 0.0005
total n-3, % 5.33 1.19 5.73 1.67 0.08
* for women n = 98.
Table 4 Spearman correlation coefficients between
plasma PL and FFQ FA *
Men (n = 100) Women (n= 100)
r p r p
ALA 0.14 0.18 0.19 0.06
EPA ** 0.11 0.26 0.44 <0.0001
DPA −0.08 0.46 0.23 0.02
DHA 0.52 <0.0001 0.5 <0.0001
total n-3 0.47 <0.0001 0.52 <0.0001
* Adjusted for age and energy intake.
** for women n= 98.
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for DPA, 60% and 75% for EPA, and 72% and 66% for
ALA for men and women, respectively.
Discussion
Results from this study demonstrate that the FFQ
appears to provide adequate information on n-3 intake
in relation to corresponding FA levels in plasma PL. In
particular, dietary intakes estimated by a FFQ were cor-
related with percentages of DHA and total n-3 FA in
plasma PL.
FFQ estimates of dietary intakes for EPA, DPA and
DHA in this young and well-educated French-Canadian
population were comparable to results reported in previ-
ous studies [27-33]. Yet, ALA and total n-3 FA intakes
were higher compared to intakes observed in earlier stud-
ies [27-33]. The estimated daily dietary intake of ALA in
most European countries and United States is of 1.3 to
1.7 g [34,35]. Thus, the higher intake of ALA may be due
to the type of vegetable oil used by this population and
thus may have beneficial effects on the cardiovascular dis-
ease risk profile. Yet, the consumption of EPA and DHA
in this young and well-educated French-Canadian study
population was below the level of 0.5 g/day recom-
mended to decrease the risk of cardiovascular disease
[36,37]. The combined daily intake of EPA and DHA was
0.25 g for men and 0.27 g for women. Similarly, Lucas
et al., examined the n-3 FA status of individuals living in
the Quebec City metropolitan area and established that
the mean daily intake of EPA and DHA was of 0.29 g
[38]. However, in our study the n-3 FA intake was higher
than that reported in the NHANES 1999–2000, where
mean intake of EPA plus DHA was approximately 0.1 g/d
[39]. Nevertheless, the present intake of EPA and DHA is
much lower than the 1.6 g daily intake observed in the
Japanese population, which has one of the lowest rates
of heart disease in the world [40].
Even though the FFQ estimates are comparable to other
studies, percentages of n-3 FA in plasma PL of the partici-
pants were lower than the percentages previously reported
in the literature [17,30,41]. In particular, plasma DHA andtotal n-3 percentage were much lower compared to the
average from the Melbourne Collaborative Cohort Study
(MCSS) (4.0-4.2% DHA and 6.6-6.8% total n-3) [30], the
European Prospective Investigation into Cancer (EPIC) -
Norfolk United Kingdom cohort (5.13-5.28% DHA and
7.81-7.96% total n-3 FA) [41], and the entire EPIC cohort
(4.6-6.6% DHA, and 6.7-10.4% total n-3)[17]. According
to several studies, FA composition stay stable for many
years when plasma is stored at −80 °C [19,21,42]; there-
fore, the poor levels of DHA and total n-3 FA observed in
the current study are unlikely to be explained by FA oxi-
dation. Overall, results indicate lower levels of n-3 FA in
plasma PL in the French-Canadian population.
Results show a modest relationship between FFQ esti-
mates of dietary intakes and percentages of n-3 FA in
plasma PL, except for ALA in women and ALA, EPA
and DPA in men. The results of the present study are in
agreement with results reported in previous studies
[15,27,28,32,43,44]. First, a validity study was conducted
in Australia for a non-specific FFQ using plasma PL
[32]. The results demonstrate significant relationships
only for DHA (0.32) and total long-chain n-3 (0.38) [32].
Secondly, Hodge et al. [27], obtained similar results
for ALA, EPA, DHA and total n-3 FA with a general
FFQ (0.07, 0.18, 0.40 and 0.31, respectively). Thirdly,
Arsenault et al. [28] demonstrated correlation coeffi-
cients of 0.37 for EPA, 0.48 for DHA and 0.48 for total
n-3 FA between an n-3 PUFA specific FFQ and plasma
PL among elderly with cognitive impairment. Finally,
earlier studies conducted with other biomarkers, such as
red blood cells, total plasma and adipose tissue, demon-
strated comparable correlation coefficients [15,43-50].
Further, these results suggest that the lack of correlation
between FFQ and plasma PL for ALA may be due to the
fact that ALA is readily metabolized to long-chain meta-
bolites, such as EPA and DHA [47,51] . Overall, the FFQ
adequately estimated DHA and total n-3 FA in the
population as well as EPA and DPA in women.
Taken together, results demonstrate modest correla-
tions (0.23-0.5) between n-3 dietary intakes estimated
using a FFQ and plasma PL. It is well accepted that per-
fect correlations between FA in tissues and intakes mea-
sured by FFQs are unrealistic. First, numerous factors
can influence the FA composition such as the tissue
used for FA profile as well as the individuals’ FA metab-
olism. Since the FFQ assesses the dietary intakes of the
last month, plasma PL should be a reasonable biomarker
to evaluate this information against as it reflects fatty
acid intake over the last 21 d [27,52]. Erythrocytes are
considered the gold standard to measure the long-term
n-3 status [53]. Yet, numerous studies have reported
strong correlations between FA content of erythrocytes
and plasma PL; therefore, plasma PL may be considered
as a reliable biomarker to reflect n-3 status over the last
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FA concentrations in tissues are subjected to other issues
such as absorption, metabolism, genetic and lifestyle
determinants [14,17,18,20]. Secondly, the FFQ data are
influenced by the capacity of individuals to recall ad-
equately food they consumed, portions they eat and by
their knowledge of food’s composition [19,21]. In addition,
the FFQ estimates are also subjected to the accuracy of
the databases used [21]. In sum, the modest correlation
coefficients observed in the current study support the abil-
ity of this FFQ to reflect the relative ranking of n-3 FA
intake.
In conclusion, our results indicate intakes of approxi-
mately 0.25 to 0.27 g/d EPA and DHA in this young and
educated French-Canadian population which is below
the recommended 0.5 g/d EPA and DHA for cardiovas-
cular disease risk reduction [34,36,37]. The present study
also indicates that n-3 FA intakes examined by FFQ and
validated with n-3 FA biomarkers, are good indicators of
n-3 FA status. Taken as a whole, the FFQ could be used
to categorize n-3 FA status, especially due to a lower
cost compared to established biomarkers. Nevertheless,
the use of the questionnaire with a less educated or
older population may be less accurate compared to this
particular French-Canadian population. Overall, the use
of this FFQ could facilitate future studies in investigating
the impact of low n-3 FA dietary intakes on health.
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